(Q42042092)

15 October 2017

Interferon-beta 1a and SARS coronavirus replication (English)

1 reference

15 October 2017

0 references

1 reference

4

1 reference

15 October 2017

6

Thomas W Geisbert

1 reference

15 October 2017

1

Lisa E Hensley

1 reference

15 October 2017

5

John W Huggins

1 reference

15 October 2017

Lisa E Fritz

2

1 reference

PMC publication ID

3322919

15 October 2017

Peter B Jahrling

series ordinal

3

1 reference

15 October 2017

1 February 2004

1 reference

Emerging Infectious Diseases

15 October 2017

1 reference

15 October 2017

10

1 reference

15 October 2017

2

1 reference

15 October 2017

317-319

1 reference

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

The Genome sequence of the SARS-associated coronavirus

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Coronavirus as a possible cause of severe acute respiratory syndrome

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Receptor-mediated pharmacokinetics and pharmacodynamics of interferon-beta1a in monkeys

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Chicken interferon type I inhibits infectious bronchitis virus replication and associated respiratory illness

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Down-regulation of Bgp1(a) viral receptor by interferon-gamma is related to the antiviral state and resistance to mouse hepatitis virus 3 infection

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322919

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15030704

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3201/EID1002.030482

1 reference

15 October 2017

1 reference

PMC publication ID

3322919

15 October 2017

PubMed publication ID

15030704

1 reference

PMC publication ID

3322919